Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | SLC34A1 | Q06495 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MMP2 | P08253 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | BLM | P54132 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5883436 | 0.95 | CA2 (0.36) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL28383117 | 0.67 | — | — | |
| SCHEMBL440939 | 0.67 | — | — | |
| SCHEMBL31058827 | 0.67 | — | — | |
| Phosphoric Acid SCHEMBL1332284 | 0.65 | — | — | |
| Phosphoric Acid SCHEMBL5907 | 0.65 | CA2 (0.56) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL3788505 | 0.65 | CA2 (0.56) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL36090 | 0.65 | CA2 (0.56) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL8851940 | 0.65 | CA2 (0.56) | CA2SLC34A1KDM4EMMP2THRB | |
| Phosphoric Acid SCHEMBL8844890 | 0.65 | CA2 (0.56) | CA2SLC34A1KDM4EMMP2THRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 149 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2669407-B1 | Galvanic baths for obtaining a low-carat gold alloy, and galvanic process that uses said baths | BLUCLAD S P A (IT) | 2022-03-30 | — | — | EP | claimed |
| US-10942190-B2 | Measurement method for amyloid precursor protein cleavage peptides | SHIMADZU CORPORATION (JP) | 2021-03-09 | — | — | US | claimed |
| US-10908167-B2 | Mass spectrometry method for polypeptides | SHIMADZU CORPORATION (JP) | 2021-02-02 | — | — | US | claimed |
| EP-2861694-B1 | HALOGEN-FREE FLAME RETARDANT TPU WITH VERY HIGH LOI | LUBRIZOL ADVANCED MAT INC (US) | 2018-10-03 | — | — | EP | claimed |
| EP-2788437-A1 | ANTI-CORROSION SYSTEM FOR STEEL | Tata Steel Nederland Technology B.V. (NL) | 2014-10-15 | — | — | EP | claimed |
| WO-2013083293-A1 | ANTI-CORROSION SYSTEM FOR STEEL | TATA STEEL NEDERLAND TECHNOLOGY BV (NL) | 2013-06-13 | — | — | WO | claimed |
| US-7052536-B2 | Water-based ink | SEIKO EPSON CORPORATION (JP) | 2006-05-30 | — | — | US | claimed |
| US-20040186200-A1 | Water-based ink | SEIKO EPSON CORPORATION | 2004-09-23 | — | — | US | claimed |
| EP-0544345-B1 | Corrosion and/or scale inhibition | FMC CORP UK LTD (GB) | 1996-08-14 | — | — | EP | claimed |
| EP-0351270-B1 | Process for the preparation of titanium oxide and articles based on titanium oxide | RHONE POULENC CHIMIE (FR) | 1994-12-28 | — | — | EP | claimed |
| US-5294371-A | Hydroxyphosphonoacetic acid derivatives | FMC CORPORATION (US) | 1994-03-15 | — | — | US | claimed |
| EP-0544345-A1 | Corrosion and/or scale inhibition | FMC CORPORATION (UK) LIMITED (GB) | 1993-06-02 | — | — | EP | claimed |
| US-5210063-A | Crush-resistant/adsorptive agglomerates of activated alumina | RHONE-POULENC CHIMIE (FR) | 1993-05-11 | — | — | US | claimed |
| EP-0351270-A1 | Process for the preparation of titanium oxide and articles based on titanium oxide | RHONE-POULENC CHIMIE (FR) | 1990-01-17 | — | — | EP | claimed |
| US-20260055288-A1 | Ink Jet Ink Composition And Recording Method | SEIKO EPSON CORP (JP) | 2026-02-26 | — | — | US | disclosed |
| US-12461092-B2 | Screening method for APP cleavage activity-controlling substances of ADAMTS4 | SHIMADZU CORPORATION (JP) | 2025-11-04 | — | — | US | disclosed |
| US-12463026-B2 | Machine difference correction method for mass spectrometry apparatus | SHIMADZU CORPORATION (JP) | 2025-11-04 | — | — | US | disclosed |
| EP-0338635-A1 | Method for controlling corrosion using molybdate compositions | CALGON CORPORATION (US) | 1989-10-25 | — | — | EP | disclosed |
| US-4798683-A | WATER SOLUBLE IONIC POLYMERS OR PHOSPHORUS COMPOUNDS | CALGON CORPORATION (US) | 1989-01-17 | — | — | US | disclosed |
| US-4302429-A | ALKALINE CARBONATE LEACHING USING HYDROGEN PEROXIDE AS OXIDANT, ALKYLIDENE-1,1-DIPHOSPHONIC ACID STABILIZER | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1981-11-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260055288-A1 | Ink Jet Ink Composition And Recording Method | JAK1, JAK3, JAK2 | CA2 751/4885SLC34A1 3149/4885KDM4E 1101/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.